Head-to-head
Epitalon vs GHK-Cu
A field-by-field comparison of Epitalon and GHK-Cu drawn from the PeptideIndex database: mechanism, evidence grade, half-life, administration route, reported dosing, side effects, storage and legal status. They belong to different categories — longevity and skin & hair — so this page focuses on what each one actually does rather than which is "better".
Epitalon vs GHK-Cu at a glance
| Attribute | Epitalon | GHK-Cu |
|---|---|---|
| Category | Longevity | Skin & hair |
| Evidence grade | Limited | Moderate |
| Also known as | Epithalon, AEDG peptide | Copper peptide, Glycyl-L-histidyl-L-lysine copper |
| Chain | Tetrapeptide (Ala-Glu-Asp-Gly) | Tripeptide (Gly-His-Lys) with copper(II) |
| Mechanism | Proposed to induce telomerase reverse transcriptase expression, allowing telomere elongation in somatic cells, and to normalise melatonin rhythm through pineal action. | Delivers copper into cells and resets gene expression toward a younger profile, upregulating collagen, elastin and glycosaminoglycan synthesis while activating antioxidant defences and hair-follicle enlargement. |
| Reported benefits | Telomere lengthening reported in cell culture · Improved sleep–wake rhythm · Longevity signals in long-running Russian cohort studies | Increased collagen and elastin production · Improved skin firmness and reduced fine lines · Hair-follicle stimulation · Accelerated wound healing |
| Reported side effects | Sparse safety data · Occasional drowsiness · Injection-site reaction | Skin irritation or redness · Copper accumulation with excessive systemic use · Injection-site swelling |
| Half-life | Minutes — effects attributed to gene expression rather than plasma level | Not applicable topically; short systemically |
| Administration | Subcutaneous injection; intranasal versions exist | Topical serum, microneedling adjunct or subcutaneous injection |
| Dosing overview | 5–10 mg daily for 10–20 days, cycled 1–3 times per year | Topical 1–3% serum daily; injectable protocols vary widely |
| Storage | Reconstituted vials refrigerated and used within the cycle | Cool, dark place; the solution is characteristically deep blue |
| Legal status | Not approved outside of Russia/CIS research contexts. | Widely available as a cosmetic ingredient; injectable use is unapproved. |
Key differences between Epitalon and GHK-Cu
Different categories, different goals
Epitalon is indexed under longevity, while GHK-Cu sits under skin & hair. They are not substitutes for one another: Epitalon is described as "A synthetic pineal peptide from Russian gerontology research, studied for telomerase activation and circadian regulation." and GHK-Cu as "A naturally occurring copper-binding tripeptide with the best-supported cosmetic profile of any peptide, plus hair and wound-healing uses."
Mechanism of action
Epitalon: Proposed to induce telomerase reverse transcriptase expression, allowing telomere elongation in somatic cells, and to normalise melatonin rhythm through pineal action. GHK-Cu: Delivers copper into cells and resets gene expression toward a younger profile, upregulating collagen, elastin and glycosaminoglycan synthesis while activating antioxidant defences and hair-follicle enlargement.
Evidence quality is not equal
Epitalon carries a Limited evidence grade and GHK-Cu a Moderate grade on this index. The grade describes the quality of published human data, not how well a compound works — GHK-Cu has the better-documented record of the two, and claims made about Epitalon rest on thinner human evidence.
Half-life and dosing frequency
Epitalon is listed at minutes — effects attributed to gene expression rather than plasma level; GHK-Cu at not applicable topically; short systemically. That difference is what drives the reported schedules: 5–10 mg daily for 10–20 days, cycled 1–3 times per year versus Topical 1–3% serum daily; injectable protocols vary widely
Route of administration
Epitalon is administered by subcutaneous injection; intranasal versions exist. GHK-Cu is administered by topical serum, microneedling adjunct or subcutaneous injection.
Legal and regulatory status differs
Epitalon: Not approved outside of Russia/CIS research contexts. GHK-Cu: Widely available as a cosmetic ingredient; injectable use is unapproved. This is usually the most practical difference between two compounds, because it determines whether a supply chain is labelled and regulated at all.
Handling and storage
Epitalon is stored reconstituted vials refrigerated and used within the cycle. GHK-Cu is stored cool, dark place; the solution is characteristically deep blue.
What Epitalon and GHK-Cu have in common
On the attributes tracked in this database — category, evidence grade, mechanism, half-life, administration, dosing overview, storage and legal status — Epitalon and GHK-Cu share no identical values. They are compared here because they come up together in the same searches, not because they overlap.
Each compound in brief
Epitalon
Longevity · Limited evidence
A synthetic pineal peptide from Russian gerontology research, studied for telomerase activation and circadian regulation.
Considerations: Key studies are decades old and largely unreplicated in the West · Telomerase activation carries a theoretical oncogenic concern · Usually run as short cycles two or three times per year
GHK-Cu
Skin & hair · Moderate evidence
A naturally occurring copper-binding tripeptide with the best-supported cosmetic profile of any peptide, plus hair and wound-healing uses.
Considerations: Topical formulations are the safest starting point · Do not combine directly with vitamin C or strong acids in the same layer · Injectable use can cause significant flushing and irritation
Related comparisons and reading
Every figure on this page is reproduced from the compound profiles in this database and reflects published literature and commonly reported protocols. It is educational information, not medical advice, and not a recommendation to use either compound. See the medical disclaimer.